ANIPANI Pharmaceuticals, Inc.
77.08USD-2.43%Mkt Cap: 1.75B USDP/E: 19.73Last update: 2026-06-01

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel …

Indicators:|

Key Statistics

Company
Market Cap1.75B USD
Enterprise Value1.97B USD
Revenue (TTM)923.71M USD
Gross Profit542.06M USD
Net Income (TTM)78.34M USD
Revenue/Share45.33 USD
Last Price77.08 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees970
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS00182C1036
Valuation
P/E (Trailing)19.73
P/E (Forward)7.40
PEG
EV/EBITDA9.97
EV/Revenue2.13
P/S1.93
P/B2.98
EPS (TTM)3.91
EPS (Forward)10.61
52W Range
57.4547% of range99.50
52W High99.50 USD
52W Low57.45 USD
Profitability
Gross Margin61.36%
Oper. Margin16.30%
EBITDA Margin21.37%
Profit Margin8.87%
ROE14.49%
ROA5.44%
Growth
Revenue Growth20.50%
Earnings Growth86.10%
Cash Flow & Leverage
Operating CF185.22M USD
CapEx (TTM)34.32M USD
FCF Margin15.18%
FCF Yield8.00%
Net Debt304.15M USD
Net Debt/EBITDA1.54
Balance Sheet
Debt/Equity1.14
Current Ratio3.12
Quick Ratio2.43
Book Value/Sh26.34 USD
Cash/Share15.38 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:6
Split DateJul 18, 2013
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)109.88 USD
Target Range90.00 USD124.00 USD
# Analysts8
Ownership
Shares Out.22.73M
Float19.46M
Insiders6.89%
Institutions110.26%
Short Interest
Short Ratio9.8d
Short % Float19.44%
Short % Out.15.93%
Shares Short3.62M
Short (prev mo.)3.49M
Technical
SMA 5078.77 (-2.1%)
SMA 20083.88 (-8.1%)
Beta0.46
S&P 52W Chg27.94%
Avg Vol (30d)333.35K
Avg Vol (10d)317.31K
Technical Indicators
RSI (14)45.2
MACD0.5016
MACD Signal0.6970
MACD Hist.-0.1954
BB Upper85.04 USD
BB Middle81.27 USD
BB Lower77.51 USD
BB Width9.26%
ATR (14)2.626 USD
Vol Ratio (20d)0.60x